Quantitation of paclitaxel in micro-sample rat plasma by a sensitive reversed-phase HPLC assay
A sensitive high-performance liquid chromatographic (HPLC) method was developed for the determination of paclitaxel in micro-samples of rat plasma in order to study the mechanism of enhanced systemic exposure of paclitaxel co-administered with P-glycoprotein inhibitors. The assay involved solid-phas...
Saved in:
Published in | Journal of pharmaceutical and biomedical analysis Vol. 31; no. 2; pp. 283 - 289 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier B.V
26.02.2003
Elsevier Science |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A sensitive high-performance liquid chromatographic (HPLC) method was developed for the determination of paclitaxel in micro-samples of rat plasma in order to study the mechanism of enhanced systemic exposure of paclitaxel co-administered with P-glycoprotein inhibitors. The assay involved solid-phase extraction procedures using 2′-methylpaclitaxel as the internal standard. Chromatographic separations were achieved using a ZORBAX ODS C18 column and mobile phase consisting of acetonitrile, methanol and ammonium acetate buffer (10 mM, pH 5.0) (48.5:16.5:35) pumped at 0.8 ml/min. The effluents were measured for UV absorption at 227 nm, with retention times of 8.5 and 11.0 min for paclitaxel and 2′-methylpaclitaxel, respectively. The chromatographic separation was excellent, with no endogenous interference. The standard curves showed a good linearity (
r=0.9994) over the concentration ranges of 10–1000 ng/ml. At 1000 ng/ml, the absolute recoveries of paclitaxel and 2′-methylpaclitaxel are 89 and 90%, respectively. The intra- and inter-day variabilities of paclitaxel were both less than 15%. This validated method for the assay of paclitaxel in micro-sample rat plasma made it feasible to study the pharmacokinetics of the drug in a single rat. |
---|---|
AbstractList | A sensitive high-performance liquid chromatographic (HPLC) method was developed for the determination of paclitaxel in micro-samples of rat plasma in order to study the mechanism of enhanced systemic exposure of paclitaxel co-administered with P-glycoprotein inhibitors. The assay involved solid-phase extraction procedures using 2'-methylpaclitaxel as the internal standard. Chromatographic separations were achieved using a ZORBAX ODS C18 column and mobile phase consisting of acetonitrile, methanol and ammonium acetate buffer (10 mM, pH 5.0) (48.5:16.5:35) pumped at 0.8 ml/min. The effluents were measured for UV absorption at 227 nm, with retention times of 8.5 and 11.0 min for paclitaxel and 2'-methylpaclitaxel, respectively. The chromatographic separation was excellent, with no endogenous interference. The standard curves showed a good linearity (r=0.9994) over the concentration ranges of 10-1,000 ng/ml. At 1,000 ng/ml, the absolute recoveries of paclitaxel and 2'-methylpaclitaxel are 89 and 90%, respectively. The intra- and inter-day variabilities of paclitaxel were both less than 15%. This validated method for the assay of paclitaxel in micro-sample rat plasma made it feasible to study the pharmacokinetics of the drug in a single rat. A sensitive high-performance liquid chromatographic (HPLC) method was developed for the determination of paclitaxel in micro-samples of rat plasma in order to study the mechanism of enhanced systemic exposure of paclitaxel co-administered with P-glycoprotein inhibitors. The assay involved solid-phase extraction procedures using 2′-methylpaclitaxel as the internal standard. Chromatographic separations were achieved using a ZORBAX ODS C18 column and mobile phase consisting of acetonitrile, methanol and ammonium acetate buffer (10 mM, pH 5.0) (48.5:16.5:35) pumped at 0.8 ml/min. The effluents were measured for UV absorption at 227 nm, with retention times of 8.5 and 11.0 min for paclitaxel and 2′-methylpaclitaxel, respectively. The chromatographic separation was excellent, with no endogenous interference. The standard curves showed a good linearity ( r=0.9994) over the concentration ranges of 10–1000 ng/ml. At 1000 ng/ml, the absolute recoveries of paclitaxel and 2′-methylpaclitaxel are 89 and 90%, respectively. The intra- and inter-day variabilities of paclitaxel were both less than 15%. This validated method for the assay of paclitaxel in micro-sample rat plasma made it feasible to study the pharmacokinetics of the drug in a single rat. |
Author | Wang, L.Z Vaddi, H.K Ho, P.C Chan, Y.W Yung, Chan Sui Lee, H.S |
Author_xml | – sequence: 1 givenname: L.Z surname: Wang fullname: Wang, L.Z organization: Department of Pharmacy, National University of Singapore, Science Drive 4, S117543, Singapore – sequence: 2 givenname: P.C surname: Ho fullname: Ho, P.C organization: Department of Pharmacology, National University of Singapore, Science Drive 4, S117543, Singapore – sequence: 3 givenname: H.S surname: Lee fullname: Lee, H.S organization: Department of Pharmacology, National University of Singapore, Science Drive 4, S117543, Singapore – sequence: 4 givenname: H.K surname: Vaddi fullname: Vaddi, H.K organization: Department of Pharmacy, National University of Singapore, Science Drive 4, S117543, Singapore – sequence: 5 givenname: Y.W surname: Chan fullname: Chan, Y.W organization: Department of Anaesthesiology, Singapore General Hospital, Outram Road, S169608, Singapore – sequence: 6 givenname: Chan Sui surname: Yung fullname: Yung, Chan Sui email: phacsy@nus.edu.sg organization: Department of Pharmacy, National University of Singapore, Science Drive 4, S117543, Singapore |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14642409$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/12609667$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkE1v1DAQQC1URLeFnwDyBQSHlLET28kJoRXQSisVBEicsGxnIowSJ3iyK_bfk-2u2iOn0WjefL0LdpbGhIw9F3AlQOi3X8GUojBQq9cg3wBoIYr6EVuJ2pSF1NWPM7a6R87ZBdFvAFCiqZ6wcyE1NFqbFfv5ZevSHGc3xzHxseOTC_2S_sWex8SHGPJYkBumHnl2M596R4Pjfs8dJ0wU57hbKrjDTNgW0y9HyK8_b9bcEbn9U_a4cz3hs1O8ZN8_fvi2vi42t59u1u83RSgbMRcKGx201zp44UuQoTN1C9iZQyiFqLsOwbfCeNe1lTIGQgit90bJslVNU16yV8e5Ux7_bJFmO0QK2Pcu4bgla0rQSkq1gOoILn8RZezslOPg8t4KsAex9k6sPVizIO2dWFsvfS9OC7Z-wPah62RyAV6eAEfB9V12KUR64CpdyQoOl747crjo2EXMlkLEFLCNGcNs2zH-55R_AzWXmQ |
CODEN | JPBADA |
CitedBy_id | crossref_primary_10_3390_pharmaceutics14051034 crossref_primary_10_1093_chromsci_bmr054 crossref_primary_10_7717_peerj_achem_3 crossref_primary_10_4155_bio_09_18 crossref_primary_10_1021_acsami_7b04066 crossref_primary_10_1093_chromsci_bmad070 crossref_primary_10_1016_j_ijpharm_2014_12_016 crossref_primary_10_1016_j_jchromb_2016_08_029 crossref_primary_10_1016_j_jpba_2005_02_023 crossref_primary_10_1016_j_msec_2011_04_011 crossref_primary_10_1080_10826070802039515 crossref_primary_10_3390_pharmaceutics14071401 crossref_primary_10_3109_10717544_2013_877100 crossref_primary_10_1016_j_jddst_2015_10_012 crossref_primary_10_1016_j_chroma_2004_12_025 crossref_primary_10_1007_s10337_016_3058_4 crossref_primary_10_1002_bmc_759 crossref_primary_10_1081_JLC_120030603 crossref_primary_10_1007_s13318_014_0203_z crossref_primary_10_1080_10826070801924402 crossref_primary_10_1002_bmc_1706 crossref_primary_10_1007_s11095_014_1304_8 crossref_primary_10_1556_AChrom_28_2016_1_8 crossref_primary_10_4155_bio_14_48 crossref_primary_10_1007_s10337_010_1903_4 crossref_primary_10_1016_j_ajps_2013_07_026 crossref_primary_10_1002_bmc_3005 crossref_primary_10_4333_KPS_2004_34_2_125 |
Cites_doi | 10.1016/0305-7372(93)90049-W 10.1016/0022-1759(93)90253-4 10.1016/0378-4347(94)00495-Q 10.1016/0378-4347(94)00456-F 10.1038/bjc.1993.488 10.1016/S0731-7085(99)00229-0 10.1016/0021-9673(96)00351-2 10.1177/10600280940280S501 10.3109/07357909509031919 10.1016/0378-4347(93)80100-I 10.1002/(SICI)1097-0231(19960731)10:10<1165::AID-RCM608>3.0.CO;2-J 10.1016/S0378-4347(98)00566-0 10.1016/S0378-4347(97)00502-1 10.1016/0378-4347(93)80341-Z 10.1016/0021-9673(94)87035-7 |
ContentType | Journal Article |
Copyright | 2002 Elsevier Science B.V. 2003 INIST-CNRS |
Copyright_xml | – notice: 2002 Elsevier Science B.V. – notice: 2003 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/S0731-7085(02)00611-8 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-264X |
EndPage | 289 |
ExternalDocumentID | 10_1016_S0731_7085_02_00611_8 12609667 14642409 S0731708502006118 |
Genre | Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 29L 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM 9JN AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARLI AATCM AAXUO ABFNM ABFRF ABJNI ABMAC ABXDB ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACNNM ACRLP ADBBV ADECG ADEZE ADMUD AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AFZHZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJQLL AJSZI ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC C45 CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FLBIZ FNPLU FYGXN G-2 G-Q GBLVA HMT HMU HVGLF HZ~ IHE J1W KOM M34 M36 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG RNS ROL RPZ SCB SCC SCH SDF SDG SDP SES SEW SPC SPCBC SPT SSK SSP SSZ T5K TEORI WUQ XFK XPP YK3 ~G- ABPIF ABPTK IQODW AAXKI AKRWK CGR CUY CVF ECM EIF NPM AAYXX AFJKZ CITATION 7X8 |
ID | FETCH-LOGICAL-c391t-5e96c6b66cb1b302cf78d0ef778d03118ffe0bd17bafd45770cccdbb7523d5993 |
IEDL.DBID | .~1 |
ISSN | 0731-7085 |
IngestDate | Fri Oct 25 07:38:46 EDT 2024 Thu Sep 26 15:47:35 EDT 2024 Sat Sep 28 08:38:09 EDT 2024 Sun Oct 22 16:05:42 EDT 2023 Fri Feb 23 02:31:11 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Reversed-phase HPLC Paclitaxel Rat plasma Solid phase extraction Biological fluid Rat Rodentia HPLC chromatography Blood plasma Vertebrata Reversed phase chromatography Mammalia Absorption Ultraviolet detector Analysis method Revcrsed-phase HPLC Animal Taxane derivatives Plant origin Pharmacokinetics Quantitative analysis |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c391t-5e96c6b66cb1b302cf78d0ef778d03118ffe0bd17bafd45770cccdbb7523d5993 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 12609667 |
PQID | 73065225 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_73065225 crossref_primary_10_1016_S0731_7085_02_00611_8 pubmed_primary_12609667 pascalfrancis_primary_14642409 elsevier_sciencedirect_doi_10_1016_S0731_7085_02_00611_8 |
PublicationCentury | 2000 |
PublicationDate | 2003-02-26 |
PublicationDateYYYYMMDD | 2003-02-26 |
PublicationDate_xml | – month: 02 year: 2003 text: 2003-02-26 day: 26 |
PublicationDecade | 2000 |
PublicationPlace | Amsterdam |
PublicationPlace_xml | – name: Amsterdam – name: England |
PublicationTitle | Journal of pharmaceutical and biomedical analysis |
PublicationTitleAlternate | J Pharm Biomed Anal |
PublicationYear | 2003 |
Publisher | Elsevier B.V Elsevier Science |
Publisher_xml | – name: Elsevier B.V – name: Elsevier Science |
References | J.G. Supko, R.V. Nair, M.V. Seiden, H. Lu, J. Pharm. Biomed. Anal. (1999) 1025–36. Liebmann, Cook, Lipschultz (BIB4) 1993; 68 Sparreboom, van Tellingen, Nooijen, Beijnen (BIB6) 1995; 664 Poon, Wade, Bloomer, Clarke, Maltas (BIB13) 1996; 10 Grothaus, Raybould, Bignami, Lazo, Byrnes (BIB11) 1993; 158 Sparreboom, de Bruijn, Nooter, Loos, Stoter, Verweij (BIB8) 1998; 705 Donehower, Rowinsky (BIB2) 1993; 19 Song, Au (BIB7) 1995; 663 Bitsch, Ma, McDonald, Nieder, Shackleton (BIB12) 1993; 615 Koeller, Burris, Dorr (BIB3) 1994; 28 Hubert, Chiap, Moors, Bourguignon, Massart (BIB15) 1994; 665 Willey, Bekos, Gaver, Duncan (BIB5) 1993; 621 Huizing, Sewberath Misser, Peters (BIB1) 1995; 13 Guidance for industry-Bioanalytical Method Validation, Internet at Leu, Chen, Schiff, Erlanger (BIB10) 1993; 53 Hempel, Lehmkuhl, Krumpelmann, Blaschke, Boos (BIB14) 1996; 745 The Merck Index, Eleventh edition, 1989. Lee, Yoo, Lee (BIB18) 1999; 724 Donehower (10.1016/S0731-7085(02)00611-8_BIB2) 1993; 19 Huizing (10.1016/S0731-7085(02)00611-8_BIB1) 1995; 13 Grothaus (10.1016/S0731-7085(02)00611-8_BIB11) 1993; 158 Poon (10.1016/S0731-7085(02)00611-8_BIB13) 1996; 10 Willey (10.1016/S0731-7085(02)00611-8_BIB5) 1993; 621 Hempel (10.1016/S0731-7085(02)00611-8_BIB14) 1996; 745 10.1016/S0731-7085(02)00611-8_BIB9 Bitsch (10.1016/S0731-7085(02)00611-8_BIB12) 1993; 615 Hubert (10.1016/S0731-7085(02)00611-8_BIB15) 1994; 665 Sparreboom (10.1016/S0731-7085(02)00611-8_BIB6) 1995; 664 Lee (10.1016/S0731-7085(02)00611-8_BIB18) 1999; 724 Song (10.1016/S0731-7085(02)00611-8_BIB7) 1995; 663 Leu (10.1016/S0731-7085(02)00611-8_BIB10) 1993; 53 Sparreboom (10.1016/S0731-7085(02)00611-8_BIB8) 1998; 705 Koeller (10.1016/S0731-7085(02)00611-8_BIB3) 1994; 28 10.1016/S0731-7085(02)00611-8_BIB17 10.1016/S0731-7085(02)00611-8_BIB16 Liebmann (10.1016/S0731-7085(02)00611-8_BIB4) 1993; 68 |
References_xml | – volume: 665 start-page: 87 year: 1994 ident: BIB15 publication-title: J. Chromatogr. A contributor: fullname: Massart – volume: 724 start-page: 357 year: 1999 end-page: 363 ident: BIB18 publication-title: J. Chromatogr. B contributor: fullname: Lee – volume: 664 start-page: 383 year: 1995 end-page: 391 ident: BIB6 publication-title: J. Chromatogr. B contributor: fullname: Beijnen – volume: 745 start-page: 173 year: 1996 end-page: 179 ident: BIB14 publication-title: J. Chromatogr. contributor: fullname: Boos – volume: 663 start-page: 337 year: 1995 end-page: 344 ident: BIB7 publication-title: J. Chromatogr. B contributor: fullname: Au – volume: 158 start-page: 5 year: 1993 end-page: 15 ident: BIB11 publication-title: J. Immunol. Methods contributor: fullname: Byrnes – volume: 10 start-page: 1165 year: 1996 end-page: 1168 ident: BIB13 publication-title: Rapid Commun. Mass. SP contributor: fullname: Maltas – volume: 615 start-page: 273 year: 1993 end-page: 280 ident: BIB12 publication-title: J. Chromatogr. contributor: fullname: Shackleton – volume: 28 start-page: S5 year: 1994 end-page: S36 ident: BIB3 publication-title: Ann. Pharmacother. contributor: fullname: Dorr – volume: 53 start-page: 1388 year: 1993 end-page: 1391 ident: BIB10 publication-title: Cancer Res. contributor: fullname: Erlanger – volume: 19 start-page: 63 year: 1993 end-page: 78 ident: BIB2 publication-title: Cancer Treat. Rev. contributor: fullname: Rowinsky – volume: 13 start-page: 381 year: 1995 end-page: 404 ident: BIB1 publication-title: Cancer Invest. contributor: fullname: Peters – volume: 68 start-page: 1104 year: 1993 end-page: 1109 ident: BIB4 publication-title: Br. J. Cancer contributor: fullname: Lipschultz – volume: 621 start-page: 231 year: 1993 end-page: 238 ident: BIB5 publication-title: J. Chromatogr. B contributor: fullname: Duncan – volume: 705 start-page: 159 year: 1998 end-page: 164 ident: BIB8 publication-title: J Chromatogr. B contributor: fullname: Verweij – volume: 19 start-page: 63 year: 1993 ident: 10.1016/S0731-7085(02)00611-8_BIB2 publication-title: Cancer Treat. Rev. doi: 10.1016/0305-7372(93)90049-W contributor: fullname: Donehower – volume: 158 start-page: 5 year: 1993 ident: 10.1016/S0731-7085(02)00611-8_BIB11 publication-title: J. Immunol. Methods doi: 10.1016/0022-1759(93)90253-4 contributor: fullname: Grothaus – volume: 664 start-page: 383 year: 1995 ident: 10.1016/S0731-7085(02)00611-8_BIB6 publication-title: J. Chromatogr. B doi: 10.1016/0378-4347(94)00495-Q contributor: fullname: Sparreboom – ident: 10.1016/S0731-7085(02)00611-8_BIB17 – volume: 663 start-page: 337 year: 1995 ident: 10.1016/S0731-7085(02)00611-8_BIB7 publication-title: J. Chromatogr. B doi: 10.1016/0378-4347(94)00456-F contributor: fullname: Song – volume: 68 start-page: 1104 year: 1993 ident: 10.1016/S0731-7085(02)00611-8_BIB4 publication-title: Br. J. Cancer doi: 10.1038/bjc.1993.488 contributor: fullname: Liebmann – ident: 10.1016/S0731-7085(02)00611-8_BIB9 doi: 10.1016/S0731-7085(99)00229-0 – volume: 53 start-page: 1388 year: 1993 ident: 10.1016/S0731-7085(02)00611-8_BIB10 publication-title: Cancer Res. contributor: fullname: Leu – volume: 745 start-page: 173 year: 1996 ident: 10.1016/S0731-7085(02)00611-8_BIB14 publication-title: J. Chromatogr. doi: 10.1016/0021-9673(96)00351-2 contributor: fullname: Hempel – volume: 28 start-page: S5 year: 1994 ident: 10.1016/S0731-7085(02)00611-8_BIB3 publication-title: Ann. Pharmacother. doi: 10.1177/10600280940280S501 contributor: fullname: Koeller – volume: 13 start-page: 381 year: 1995 ident: 10.1016/S0731-7085(02)00611-8_BIB1 publication-title: Cancer Invest. doi: 10.3109/07357909509031919 contributor: fullname: Huizing – volume: 621 start-page: 231 year: 1993 ident: 10.1016/S0731-7085(02)00611-8_BIB5 publication-title: J. Chromatogr. B doi: 10.1016/0378-4347(93)80100-I contributor: fullname: Willey – volume: 10 start-page: 1165 year: 1996 ident: 10.1016/S0731-7085(02)00611-8_BIB13 publication-title: Rapid Commun. Mass. SP doi: 10.1002/(SICI)1097-0231(19960731)10:10<1165::AID-RCM608>3.0.CO;2-J contributor: fullname: Poon – ident: 10.1016/S0731-7085(02)00611-8_BIB16 – volume: 724 start-page: 357 year: 1999 ident: 10.1016/S0731-7085(02)00611-8_BIB18 publication-title: J. Chromatogr. B doi: 10.1016/S0378-4347(98)00566-0 contributor: fullname: Lee – volume: 705 start-page: 159 year: 1998 ident: 10.1016/S0731-7085(02)00611-8_BIB8 publication-title: J Chromatogr. B doi: 10.1016/S0378-4347(97)00502-1 contributor: fullname: Sparreboom – volume: 615 start-page: 273 year: 1993 ident: 10.1016/S0731-7085(02)00611-8_BIB12 publication-title: J. Chromatogr. doi: 10.1016/0378-4347(93)80341-Z contributor: fullname: Bitsch – volume: 665 start-page: 87 year: 1994 ident: 10.1016/S0731-7085(02)00611-8_BIB15 publication-title: J. Chromatogr. A doi: 10.1016/0021-9673(94)87035-7 contributor: fullname: Hubert |
SSID | ssj0005194 |
Score | 1.8831956 |
Snippet | A sensitive high-performance liquid chromatographic (HPLC) method was developed for the determination of paclitaxel in micro-samples of rat plasma in order to... |
SourceID | proquest crossref pubmed pascalfrancis elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 283 |
SubjectTerms | Animals Antineoplastic agents Antineoplastic Agents, Phytogenic - blood Antineoplastic Agents, Phytogenic - pharmacokinetics Biological and medical sciences Chromatography, High Pressure Liquid - methods General aspects Medical sciences Paclitaxel Paclitaxel - blood Paclitaxel - pharmacokinetics Pharmacology. Drug treatments Rat plasma Rats Reproducibility of Results Reversed-phase HPLC Sensitivity and Specificity |
Title | Quantitation of paclitaxel in micro-sample rat plasma by a sensitive reversed-phase HPLC assay |
URI | https://dx.doi.org/10.1016/S0731-7085(02)00611-8 https://www.ncbi.nlm.nih.gov/pubmed/12609667 https://search.proquest.com/docview/73065225 |
Volume | 31 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CegmU0iZ9bNps51BCC1HWXj9kH8PSsEnbsKUJ5FQh2RJZSLwm3oXupb-9M7IXN4dQ6MkgJFnMJ42-secB8MHmzlniFaJMx1zCLKczFyWRsLEjfZnpPHQc4PztIp1exefXyfUWTDaxMOxW2en-Vqd7bd21jDppjur5fPSDNmcoOeMaW8XEkzmCPfGH8_j3X24eoS-GyJ0F9-6jeNoZfOPHYPzJTyKyx-6np7VuSGquLXfxOB_199Lpc3jWEUo8adf8ArZstQuHszYj9foIL_sAq-YID3HW56pe78HP7ytdLbs83bhwSCY0p-3-ZW9xXuEdu-uJRnMKYaS9gjWR7TuNZo0aG_Z9Z22JnAbqvrGlqG_oUsTp7OsEiZTr9Uu4Ov18OZmKruSCKKI8XIrE5mmRmjQtTGiiYFw4mZWBdZIfEQmZkA1MGUqjXRknUgZFUZTGSLJny4S4zivYrhaVfQNISEv-EBrFiY3JMMlCLvSjy5wIJY2LB3C8EbSq28waqnc5I2QUI6OCsfLIqGwA2QYO9WCLKNL-_xo6fABf_8KY7C8ycQfwfoOnovPFP010ZRerRpEGTImjJgN43cLcjyVTkIxFuf__63oLO945kEPk03ewvbxf2QMiOUsz9Lt4CE9Ozr5ML_4AvEz1VQ |
link.rule.ids | 315,783,787,4511,24130,27938,27939,45599,45693 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEB7S5NBCKenbbZPMoYQWsrVkPVY6BtOgNI5xqQM5ddmVdqmhkUVkQ_3vOyPJiBxCICfBolmJ_WZnv5HmAfDZps5Z4hWiiEfcwiylPRdEgbChI3uZ6NR3nOB8OY2zq_DHdXS9A-NtLgyHVXa2v7XpjbXuRobdag6rxWL4i5TTl1xxjb1i4slPYI_YQErKvnd6fpFN-0gPv-mHyPcLFugTedpJmsEv3uhrM49I7juinle6poVzbceL-ylpczSd7cOLjlPiafvaL2HHlq_geNYWpd6c4LzPsapP8BhnfbnqzWv4_XOty1VXqhuXDsmL5srd_-xfXJR4wxF7otZcRRhJXbAivn2j0WxQY83h72wwkStB3da2ENUfOhcxm03GSLxcb97A1dn3-TgTXdcFkQepvxKRTeM8NnGcG98E3ih3Mik86yRfAlpnAtczhS-NdkUYSenleV4YI8mlLSKiO29ht1yW9j0ggS35W2gQRjYk3yTxudePLlLilCQXDuDbdqFV1RbXUH3UGSGjGBnljVSDjEoGkGzhUHe0RNEB8JDo4R34-geG5IKRlzuAoy2eirYY_zfRpV2ua0VGMCaaGg3gXQtzL0veIPmL8sPj3-sInmbzy4manE8vPsKzJlaQM-bjT7C7ul3bA-I8K3PY6fR_VNr4Eg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quantitation+of+paclitaxel+in+micro-sample+rat+plasma+by+a+sensitive+reversed-phase+HPLC+assay&rft.jtitle=Journal+of+pharmaceutical+and+biomedical+analysis&rft.au=WANG%2C+L.+Z&rft.au=HO%2C+P.+C&rft.au=LEE%2C+H.+S&rft.au=VADDI%2C+H.+K&rft.date=2003-02-26&rft.pub=Elsevier+Science&rft.issn=0731-7085&rft.eissn=1873-264X&rft.volume=31&rft.issue=2&rft.spage=283&rft.epage=289&rft_id=info:doi/10.1016%2FS0731-7085%2802%2900611-8&rft.externalDBID=n%2Fa&rft.externalDocID=14642409 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0731-7085&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0731-7085&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0731-7085&client=summon |